INMD
Inmode Ltd (INMD)
Healthcare • NASDAQ • $13.96+0.29%
- Symbol
- INMD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $13.96
- Daily Change
- +0.29%
- Market Cap
- $848.89M
- Trailing P/E
- 10.34
- Forward P/E
- 9.45
- 52W High
- $16.74
- 52W Low
- $12.72
- Analyst Target
- $15.50
- Dividend Yield
- N/A
- Beta
- N/A
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearanc…
Company websiteResearch INMD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.